India's Drugs Technical Advisory Board decides against waiving clinical trials for In-vitro Diagnostics despite their approval in other countries due to biological, genetic, and environmental differences. This decision reflects the importance of local validation in ensuring IVD performance within the Indian context. The IVD market is projected to grow significantly. Read The Rest at :
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.
